Cargando…
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
The current pandemic has highlighted the need for methodologies that can quickly and reliably prioritize clinically approved compounds for their potential effectiveness for SARS-CoV-2 infections. In the past decade, network medicine has developed and validated multiple predictive algorithms for drug...
Autores principales: | Morselli Gysi, Deisy, Do Valle, Ítalo, Zitnik, Marinka, Ameli, Asher, Gan, Xiao, Varol, Onur, Ghiassian, Susan Dina, Patten, JJ, Davey, Robert, Loscalzo, Joseph, Barabási, Albert-László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cornell University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280907/ https://www.ncbi.nlm.nih.gov/pubmed/32550253 |
Ejemplares similares
-
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
por: Morselli Gysi, Deisy, et al.
Publicado: (2021) -
Noncoding RNAs improve the predictive power of network medicine
por: Morselli Gysi, Deisy, et al.
Publicado: (2023) -
Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization
por: Patten, J.J., et al.
Publicado: (2022) -
Tissue Specificity of Human Disease Module
por: Kitsak, Maksim, et al.
Publicado: (2016) -
Construction, comparison and evolution of networks in life sciences and other disciplines
por: Gysi, Deisy Morselli, et al.
Publicado: (2020)